- Home
- FSI vs IKNA Comparison
FSI vs IKNA Comparison
Compare FSI & IKNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSI
- IKNA
- Stock Information
- Founded
- FSI 1991
- IKNA 2016
- Country
- FSI Canada
- IKNA United States
- Employees
- FSI N/A
- IKNA N/A
- Industry
- FSI Recreational Games/Products/Toys
- IKNA Biotechnology: Pharmaceutical Preparations
- Sector
- FSI Consumer Discretionary
- IKNA Health Care
- Exchange
- FSI Nasdaq
- IKNA Nasdaq
- Market Cap
- FSI 55.6M
- IKNA 52.1M
- IPO Year
- FSI 1999
- IKNA 2021
- Fundamental
- Price
- FSI $4.32
- IKNA $1.42
- Analyst Decision
- FSI
- IKNA Strong Buy
- Analyst Count
- FSI 0
- IKNA 1
- Target Price
- FSI N/A
- IKNA $4.00
- AVG Volume (30 Days)
- FSI 27.7K
- IKNA 101.8K
- Earning Date
- FSI 05-15-2025
- IKNA 05-08-2025
- Dividend Yield
- FSI 2.27%
- IKNA N/A
- EPS Growth
- FSI N/A
- IKNA N/A
- EPS
- FSI 0.18
- IKNA N/A
- Revenue
- FSI $36,483,680.00
- IKNA N/A
- Revenue This Year
- FSI $21.91
- IKNA N/A
- Revenue Next Year
- FSI $42.35
- IKNA N/A
- P/E Ratio
- FSI $24.18
- IKNA N/A
- Revenue Growth
- FSI N/A
- IKNA N/A
- 52 Week Low
- FSI $1.65
- IKNA $0.97
- 52 Week High
- FSI $7.24
- IKNA $1.94
- Technical
- Relative Strength Index (RSI)
- FSI 50.69
- IKNA 70.01
- Support Level
- FSI $4.22
- IKNA $1.10
- Resistance Level
- FSI $4.55
- IKNA $1.40
- Average True Range (ATR)
- FSI 0.23
- IKNA 0.07
- MACD
- FSI -0.00
- IKNA 0.03
- Stochastic Oscillator
- FSI 42.59
- IKNA 97.20
About FSI Flexible Solutions International Inc. (CDA)
Flexible Solutions International Inc develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Its business is organized into two segments: Energy and Water Conservation Products and Biodegradable Polymers. It offers a liquid swimming pool blanket under the WATERSAVR brand, which saves energy and water by inhibiting evaporation from the pool surface, and a chemical product called HEATSAV for use in swimming pools and spas to slow water evaporation. The firm also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers. It generates the majority of its revenues from the export of its products to international markets.
About IKNA Ikena Oncology Inc.
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.